Drug

Antibiotics may work, but they drive bacteria to evolve into new drug-resistant forms. Now a new study has uncovered a mechanism that could make the bugs non-infectious without killing them, reducing the evolutionary pressure that leads to superbugs.

Difficult to detect and with a low survival rate, pancreatic cancer is one of the most insidious forms of the disease. But now, researchers have identified an existing drug that could fight pancreatic cancer by targeting a key gene mutation.

Bacteria are extremely good at evolving in response to drugs, which can render vaccines ineffective. But now, researchers at ETH Zurich have found a way to weaponize that ability against them, forcing the bugs down harmless evolutionary dead ends.

Getting drugs into the brain is no easy feat, but the nose is one of the most direct routes. Now, UK researchers have developed a nasal spray hydrogel that lines the tissue in the nose to deliver a common Parkinson’s drug straight to the brain.

Scientists at Cambridge have demonstrated a new method to fight leukemia, by targeting overactive enzymes that can lead to the disease. If the results of mice tests carry across to humans, it could be the first of a new class of cancer drugs.

Scientists at Purdue University and Scripps have identified a natural compound from a common shrub that could help fight cancer. The compound is the first found to inhibit a cancer protein that was previously considered “undruggable.”

For millions of patients with diabetes, daily insulin injections are a necessary nuisance. A once-a-week shot might be more palatable, and new results from phase 2 clinical trials suggest just such a drug is safe and effective.

An oral pill would be much easier for diabetics than daily insulin injections. An experimental new method for packing insulin into capsules helps it survive the trip through the stomach to the bloodstream, and releases its payload only when needed.

Antibiotic-resistant bacteria are an urgent public health threat. A new single-dose drug has been developed that works on a different mechanism to most antibiotics, and tests in mice show that it can be used to treat multi-drug-resistant gonorrhea.

Antibiotic-resistant “superbugs" pose a serious public health threat. New antibiotics are needed to turn the tide, but developing them takes time. Now IBM Research has set AI on the task, producing two promising new drug candidates very quickly.

HIV can currently be managed with a lifelong daily drug regimen, but unfortunately the infection can’t be eliminated entirely. Now researchers may have found a way to trip a cellular “alarm” to alert the immune system to clear out infected cells.

Stanford scientists have developed a new hydrogel with a Velcro-like molecular structure, letting it last longer at body temperature. The hope is that it could be injected into a patient to deliver drugs over weeks or months as it slowly dissolves.